Acute hepatic failure involving duloxetine hydrochloride

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 24, Issue 2, 2012, Pages 48-49

  Yuan, Weiqing ^a   Williams, Barry ^a  

^a FORSYTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; BUPRENORPHINE PLUS NALOXONE; DIAZEPAM; DULOXETINE; FLUTICASONE PROPIONATE PLUS SALMETEROL; INFUSION FLUID; LACTULOSE; PANTOPRAZOLE; PARACETAMOL; SALBUTAMOL; TRAZODONE;

ACUTE LIVER FAILURE; ADULT; ANXIETY DISORDER; ARTICLE; ASTHMA; CASE REPORT; CHOLECYSTECTOMY; CHRONIC LIVER DISEASE; CHRONIC PAIN; DEPRESSION; DRUG DOSE INCREASE; DRUG WITHDRAWAL; FATTY LIVER; FEMALE; FLAPPING TREMOR; HUMAN; NAUSEA; PATIENT MONITORING; PRIORITY JOURNAL; ULTRASOUND; VOMITING;

EID: 84865132164     PISSN: 08950172     EISSN: 15457222     Source Type: Journal    
DOI: 10.1176/appi.neuropsych.11040083     Document Type: Article

References (6)

1. Carter NJ, McCormack PL: Duloxetine: a review of its use in the treatment of generalized anxiety disorder. CNS Drugs 2009; 23:523-541
2. Scholz BA, Hammonds CL, Boomershine CS: Duloxetine for the management of fibro-myalgia syndrome. J Pain Res 2009; 2:99-108
3. Hurley DJ, Turner CL, Yalcin I, et al: Duloxetine for the treatment of stress urinary incontinence in women: an integrated analysis of safety. Eur J Obstet Gynecol Reprod Biol 2006; 125:120-128
4. Park YM, Lee BH, Lee HJ, et al: Cholestatic jaundice induced by duloxetine in a patient with major depressive disorder. Psychiatry Investig 2010; 7:228-230
5. Vey EL, Kovelman I: Adverse events, toxicity and post-mortem data on duloxetine: case reports and literature survey. J Forensic Leg Med 2010; 17:175-185
6. Hanje AJ, Pell LJ, Votolato NA, et al: Case report: fulminant hepatic failure involving duloxetine hydrochloride. Clin Gastroenterol Hepatol 2006; 4:912-917